[ Price : $8.95]
Federal Register notice: FDA reschedules a previously planned drug safety advisory committee involving opioid overdose risk studie...[ Price : $8.95]
A report on the 2024 Global Summit on Regulatory Science calls for a collaborative global effort to harness artificial intelligenc...[ Price : $8.95]
Three FDA staffers discuss the agencys efforts to advance the use of digital health technologies in clinical trials.[ Price : $8.95]
Recent FDA layoffs raise concerns across the drug and biologic industries as experts warn that diminished inspection capacity coul...[ Price : $8.95]
FDA appoints Capitol Hill staffer Grace Graham as deputy commissioner for policy, legislation, and international affairs.[ Price : $8.95]
FDA is recruiting contractors to do the travel logistics work for inspections and investigations that was done by staff who have b...[ Price : $8.95]
FDA issues two documents answering frequently asked questions about reporting medical device recalls, corrections, and adverse eve...[ Price : $8.95]
FDA grants interchangeable biosimilar status to Celltrions Yuflyma (adalimumab-aaty), a biosimilar copy of AbbVies Humira.